feed,title,long_url,short_url
Benzinga,Daiichi-AstraZeneca's Flagship Cancer Drug Scores FDA Approval For Lung Cancer Harboring HER2 Mutation,https://benzinga.com/general/biotech/22/08/28472006/daiichi-astrazenecas-flagship-cancer-drug-scores-fda-approval-for-lung-cancer-harboring-her2-muta,https://bit.ly/3w1LQV3
